Post-translational addition of O-linked N-acetylglucosamine (O-GlcNAc) to p53 is known to occur, but the site of O-GlcNAcylation and its effects on p53 are not understood. Here, we show that Ser 149 of p53 is O-GlcNAcylated and that this modification is associated with decreased phosphorylation of p53 at Thr 155, which is a site that is targeted by the COP9 signalosome, resulting in decreased p53 ubiquitination. Accordingly, O-GlcNAcylation at Ser 149 stabilizes p53 by blocking ubiquitin-dependent proteolysis. Our results indicate that the dynamic interplay between O-GlcNAc and O-phosphate modifications coordinately regulate p53 stability and activity.

The transcription factor NFB is activated by phosphorylation and acetylation and plays important roles in inflammatory and immune responses in the cell. Additionally, posttranslational modification of the NFB p65 subunit by O-linked N-acetylglucosamine (OGlcNAc) has been reported, but the modification site of O-GlcNAc on NFB p65 and its exact function have not been elucidated. In this work, we show that O-GlcNAcylation of NFB p65 decreases binding to IB␣ and increases transcriptional activity under hyperglycemic conditions. Also, we demonstrate that both Thr-322 and Thr-352 of NFB p65 can be modified with O-GlcNAc, but modification on Thr-352, not Thr-322, is important for transcriptional activation. Our findings suggest that site-specific O-GlcNAcylation may be a reason why NFB activity increases continuously under hyperglycemic conditions.T ranscription factor NFB plays important roles in inflammatory, immune, and antiapoptotic responses (1-3). In mammals, NFB is present as a dimer composed of various combinations of Rel proteins such as p65 (RelA), RelB, c-Rel, p50/p105, and p52/p100. In most cell types, NFB is composed of p65 and p50 and is localized in the cytosol where it binds inhibitor (IB). Treatment with NFB-activating agents such as tumor necrosis factor ␣ (TNF␣) activates IB kinase (IKK) complexes, inducing phosphorylation in the N terminus of IB. The phosphorylation event induces IB degradation via a ubiquitin-dependent proteolysis. Free NFB translocates to the nucleus and activates the expression of target genes (1, 2).Posttranslational modifications such as phosphorylation (4-9) and acetylation (10, 11) regulate the transcriptional activity of NFB. The activity of NFB is influenced also by the hexosamine biosynthetic pathway, which produces a substrate of O-GlcNAcylation, UDP-GlcNAc (12). Many nucleocytoplasmic proteins are known to be dynamically modified with O-GlcNAc. This modification is modulated by O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA) (13-18). O-GlcNAcylation levels play an important role in transcription, translation, nuclear transport, protein stability, and protein-protein interactions and can be increased under hyperglycemic conditions caused by diabetes (16 -18). Although it is known that O-GlcNAcylation of NFB is involved in hyperglycemia-induced NFB activation (12) and is required for lymphocyte activation (19), the specific sites and the function of O-GlcNAcylation on NFB are not well understood.In this work, we show that OGA overexpression downregulates O-GlcNAcylation and inhibits hyperglycemia-induced NFB activation in rat vascular smooth muscle cells (VSMCs). In contrast, up-regulation of O-GlcNAcylation after OGT overexpression and treatment of cells with the O-GlcNAcase inhibitors streptozotocin (STZ) (20) and O-(2-acetamido-2-deoxy-Dglucopyranosylidene)amino-N-phenylcarbamate (PUGNAc)(21) increase NFB transcriptional activity. Additionally, we identify Thr-322 and Thr-352 as O-GlcNAcylation sites in a mutation study and with mass spectrometry analysis. Our data sho...

Protein O-phosphorylation often occurs reciprocally with O-GlcNAc modification and represents a regulatory principle for proteins. O-phosphorylation of serine by glycogen synthase kinase-3b on Snail1, a transcriptional repressor of E-cadherin and a key regulator of the epithelial-mesenchymal transition (EMT) programme, results in its proteasomal degradation. We show that by suppressing O-phosphorylation-mediated degradation, O-GlcNAc at serine112 stabilizes Snail1 and thus increases its repressor function, which in turn attenuates E-cadherin mRNA expression. Hyperglycaemic condition enhances O-GlcNAc modification and initiates EMT by transcriptional suppression of E-cadherin through Snail1. Thus, dynamic reciprocal O-phosphorylation and OGlcNAc modification of Snail1 constitute a molecular link between cellular glucose metabolism and the control of EMT.

Intestinal inflammation is the central pathological feature of colitis and the inflammatory bowel diseases. These syndromes arise from unidentified environmental factors. We found that recurrent non-lethal gastric infections of Gram-negative Salmonella enterica Typhimurium (ST), a major source of human food poisoning, caused inflammation of murine intestinal tissue, predominantly the colon, which persisted following pathogen clearance and irreversibly escalated in severity with repeated infections. ST progressively disabled a host mechanism of protection by inducing endogenous neuraminidase activity thereby accelerating the molecular aging and clearance of intestinal alkaline phosphatase (IAP). Disease was linked to a Tlr4-dependent mechanism of IAP desialylation and deficiency with resulting accumulation of lipopolysaccharide-phosphate (LPS-P). Oral administration of IAP or the marketed anti-viral neuraminidase inhibitor Zanamivir were therapeutic by maintaining IAP dephosphorylation of LPS-P.